[1] BAHAREH K, AHMADREZA Y, HOSEIN M.Evaluating the efficacy of nanosil mouthwash on the preventing pulmonary infection in intensive care unit: a randomized clinical trial[J]. Med Arch, 2018, 72(3):206-209. [2] HOGEA SP, TUDORACHE E, FILDAN AP, et al.Risk factors of chronic obstructive pulmonary disease exacerbations[J]. Clin Respir J, 2020, 14(3):183-197. [3] MARC M, ANTONIO A.Chronic respiratory infection in patients with chronic obstructive pulmonary disease: what is the role of antibiotics?[J]. Int J Molr Sci, 2017, 18(7):1344. [4] SUN S, WANG F, YU M, et al.Clinical study of serum procalcitonin level in patients with myocardial infarction complicated by pulmonary infection[J]. Exp Ther Med, 2018, 16(6):5210-5214. [5] 刘巍, 马青松. 血清IL-6, IL-17水平对AECOPD合并肺部感染的早期诊断价值及病原菌分析[J]. 分子诊断与治疗杂志, 2022, 14(1):82-85. [6] LUO Y, LI C, ZHOU Z, et al.Biological functions of IL-17-producing cells in mycoplasma respiratory infection[J]. Immunology, 2021, 164(2):223-230. [7] 陈琳玲, 唐卫东, 陈琪, 等. 营养治疗及质量改进对县级ICU慢性阻塞性肺疾病患者预后影响[J]. 中华急诊医学杂志, 2019, 28(4):463-466. [8] MEHTA A, BREWINGTON R, CHATTERJI M, et al.Infection-induced modulation of m1 and m2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis.[J]. Shock, 2004, 22(5):423-430. [9] 中华医学会呼吸病学分会. 社区获得性肺炎诊断和治疗指南[J]. 中国实用乡村医生杂志, 2006, 20(3):158-160. [10] 叶任高, 陆再英, 谢毅, 等. 内科学[M]. 7版.北京:人民卫生出版社, 2009:143. [11] 李君, 姚蓉, 易春梅, 等. 便携式纤维支气管镜肺泡灌洗对老年呼吸衰竭合并肺部感染患者Th1/Th2细胞因子的影响[J]. 中华医院感染学杂志, 2020, 30(21):3268-3271. [12] 封占辉. ICU呼吸衰竭并肺部感染患者的病原学及耐药性分析[J]. 中华养生保健, 2020, 38(2):50-51. [13] EZZELL L, JENSEN GL.Malnutrition in chronic obstructive pulmonary disease[J]. Am J Clinl Nutr, 2000, 72(6):1415-1416. [14] HOONG JM, FERGUSON M, HUKINS C, et al.Economic and operational burden associated with malnutrition in chronic obstructive pulmonary disease[J]. Clin Nutr, 2017,36(4):1105-1109. [15] PRESCOTT HC, SJODING MW, LANGA KM, et al.Late mortality after acute hypoxic respiratory failure[J]. Thorax, 2017, 73(7):618-625. [16] 陈晓珊, 李希, 杨荀. 影响老年重症肺炎合并急性呼吸衰竭预后的危险因素分析[J]. 实用老年医学, 2019, 33(11):1117-1120. [17] BRANCHE A, NEESER O, MUELLER B, et al.Procalcitonin to guide antibiotic decision making[J]. Curr Opin Infect Dis, 2019, 32(2):130-135. [18] 杨海燕, 付朝晖, 王喜春, 等. 降钙素原及C反应蛋白在高龄慢性阻塞性肺疾病急性加重期患者中的诊断价值[J]. 重庆医学, 2014, 43(32):4314-4315,4319. [19] 荆梦君. PCT, IL-6, D-D水平与脓毒症严重程度和预后的相关性分析[J]. 中外医学研究, 2022, 20(3):66-70. [20] FITZGERALD KA, KAGAN JC.Toll-like receptors and the control of immunity[J]. Cell, 2020, 180(6):1044-1066. [21] 贾国泉, 沈桂权, 张权, 等. TOLL受体介导的MYD88/TRAF6/NF-κB研究[J/CD]. 新发传染病电子杂志, 2017, 2(2):104-107. [22] MILLS KHG.IL-17 and IL-17-producing cells in protection versus pathology[J]. Nat Rev Immunol, 2023, 23(1):38-54. [23] ONISHI RM, GAFFEN SL.Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease[J]. Immunology, 2010, 129(3):311-321. |